675 related articles for article (PubMed ID: 34142203)
1. Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey.
Cherian S; Paul A; Ahmed S; Alias B; Manoj M; Santhosh AK; Varghese DR; Krishnan N; Shenoy P
Rheumatol Int; 2021 Aug; 41(8):1441-1445. PubMed ID: 34142203
[TBL] [Abstract][Full Text] [Related]
2. Covid-19 vaccination in autoimmune rheumatic diseases: A multi-center survey from southern India.
Mohanasundaram K; Santhanam S; Natarajan R; Murugesan H; Nambi T; Chilikuri B; Nallasivan S
Int J Rheum Dis; 2022 Sep; 25(9):1046-1052. PubMed ID: 35773944
[TBL] [Abstract][Full Text] [Related]
3. Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study.
Esquivel-Valerio JA; Skinner-Taylor CM; Moreno-Arquieta IA; Cardenas-de la Garza JA; Garcia-Arellano G; Gonzalez-Garcia PL; Almaraz-Juarez FDR; Galarza-Delgado DA
Rheumatol Int; 2021 Dec; 41(12):2105-2108. PubMed ID: 34622311
[TBL] [Abstract][Full Text] [Related]
4. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey.
Gaur P; Agrawat H; Shukla A
Rheumatol Int; 2021 Sep; 41(9):1601-1605. PubMed ID: 34213580
[TBL] [Abstract][Full Text] [Related]
6. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
Machado PM; Lawson-Tovey S; Strangfeld A; Mateus EF; Hyrich KL; Gossec L; Carmona L; Rodrigues A; Raffeiner B; Duarte C; Hachulla E; Veillard E; Strakova E; Burmester GR; Yardımcı GK; Gomez-Puerta JA; Zepa J; Kearsley-Fleet L; Trefond L; Cunha M; Mosca M; Cornalba M; Soubrier M; Roux N; Brocq O; Durez P; Conway R; Goulenok T; Bijlsma JW; McInnes IB; Mariette X
Ann Rheum Dis; 2022 May; 81(5):695-709. PubMed ID: 34972811
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of inactivated SARS-CoV-2 vaccination in COVID-19-associated pneumonia among patients with rheumatic and musculoskeletal diseases: A real-world retrospective observational study.
Liu S; Jin Z; Feng X; Da Z; Tang Y; Hu H; Wang D; Sun L
Int J Rheum Dis; 2024 May; 27(5):e15166. PubMed ID: 38720417
[TBL] [Abstract][Full Text] [Related]
8. Is vaccination against COVID-19 associated with autoimmune rheumatic disease flare? A self-controlled case series analysis.
Nakafero G; Grainge MJ; Card T; Mallen CD; Nguyen Van-Tam JS; Williams HC; Abhishek A
Rheumatology (Oxford); 2023 Apr; 62(4):1445-1450. PubMed ID: 36048896
[TBL] [Abstract][Full Text] [Related]
9. Incidence and severity of COVID-19 infection post-vaccination: a survey among Indian doctors.
Parameswaran A; Apsingi S; Eachempati KK; Dannana CS; Jagathkar G; Iyer M; Aribandi H
Infection; 2022 Aug; 50(4):889-895. PubMed ID: 35129788
[TBL] [Abstract][Full Text] [Related]
10. Boosting Vaccine Response in Autoimmune Rheumatic Disease Patients With Inadequate Seroconversion: An Analysis of the Immunogenicity of Vector-Based and Inactivated Vaccines.
Vijayan A; Sukumaran A; Jones S; Paul A; Ahmed S; Mehta P; Mohanan M; Kumar S; Easwaran S; Shenoy P
Cureus; 2024 Mar; 16(3):e55764. PubMed ID: 38586774
[TBL] [Abstract][Full Text] [Related]
11. Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.
Frommert LM; Arumahandi de Silva AN; Zernicke J; Scholz V; Braun T; Jeworowski LM; Schwarz T; Tober-Lau P; Ten Hagen A; Habermann E; Kurth F; Sander LE; Corman VM; Burmester GR; Biesen R; Albach FN; Klotsche J
RMD Open; 2022 Dec; 8(2):. PubMed ID: 36597977
[TBL] [Abstract][Full Text] [Related]
12. Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine.
Spinelli FR; Favalli EG; Garufi C; Cornalba M; Colafrancesco S; Conti F; Caporali R
Arthritis Res Ther; 2022 Jan; 24(1):21. PubMed ID: 35016701
[TBL] [Abstract][Full Text] [Related]
13. Inactivated vaccines may not provide adequate protection in immunosuppressed patients with rheumatic diseases.
Shenoy P; Ahmed S; Paul A; Cherian S; Vijayan A; Babu SA; Sukumaran A
Ann Rheum Dis; 2022 Feb; 81(2):295-296. PubMed ID: 34635493
[No Abstract] [Full Text] [Related]
14. Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease.
Mehta P; Paul A; Ahmed S; Cherian S; Panthak A; Benny J; Shenoy P
Clin Rheumatol; 2022 Nov; 41(11):3537-3542. PubMed ID: 35760938
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis.
Naveen R; Parodis I; Joshi M; Sen P; Lindblom J; Agarwal V; Lilleker JB; Tan AL; Nune A; Shinjo SK; Salim B; Ziade N; Velikova T; Edgar Gracia-Ramos A; Saavedra MA; Day J; Makol A; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L; Nikiphorou E;
Rheumatology (Oxford); 2023 Jul; 62(7):2366-2376. PubMed ID: 36315075
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
Lazarus R; Baos S; Cappel-Porter H; Carson-Stevens A; Clout M; Culliford L; Emmett SR; Garstang J; Gbadamoshi L; Hallis B; Harris RA; Hutton D; Jacobsen N; Joyce K; Kaminski R; Libri V; Middleditch A; McCullagh L; Moran E; Phillipson A; Price E; Ryan J; Thirard R; Todd R; Snape MD; Tucker D; Williams RL; Nguyen-Van-Tam JS; Finn A; Rogers CA;
Lancet; 2021 Dec; 398(10318):2277-2287. PubMed ID: 34774197
[TBL] [Abstract][Full Text] [Related]
17. Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience.
Kim SH; Wi YM; Yun SY; Ryu JS; Shin JM; Lee EH; Seo KH; Lee SH; Peck KR
J Korean Med Sci; 2021 Apr; 36(14):e107. PubMed ID: 33847085
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin.
Kant R; Dwivedi G; Zaman K; Sahay RR; Sapkal G; Kaushal H; Nyayanit DA; Yadav PD; Deshpande G; Singh R; Chaowdhary S; Gupta N; Kumar S; Abraham P; Panda S; Bhargava B
J Travel Med; 2021 Dec; 28(8):. PubMed ID: 34652440
[TBL] [Abstract][Full Text] [Related]
19. Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink.
Nakafero G; Grainge MJ; Myles PR; Mallen CD; Zhang W; Doherty M; Nguyen-Van-Tam JS; Abhishek A
Ann Rheum Dis; 2019 Aug; 78(8):1122-1126. PubMed ID: 31036623
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study.
Doskaliuk B; Ravichandran N; Sen P; Day J; Joshi M; Nune A; Nikiphorou E; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Jagtap K; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Chen YM; Makol A; Agarwal V; Patel A; Pauling JD; Wincup C; Barman B; Tehozol EAZ; Serrano JR; La Torre IG; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Goo PA; Shumnalieva R; Hoff LS; Kibbi LE; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Gutiérrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; ; Chinoy H; Agarwal V; Aggarwal R; Gupta L
Rheumatol Int; 2023 Sep; 43(9):1651-1664. PubMed ID: 37351634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
